Best Financial Stocks To Own Right Now


Korea Investment CORP cut its position in shares of Valeant Pharmaceuticals (NYSE:VRX) (TSE:VRX) by 46.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 126,736 shares of the specialty pharmaceutical company’s stock after selling 109,300 shares during the quarter. Korea Investment CORP’s holdings in Valeant Pharmaceuticals were worth $2,948,000 at the end of the most recent reporting period.


Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Envestnet Asset Management Inc. grew its holdings in Valeant Pharmaceuticals by 189.4% in the first quarter. Envestnet Asset Management Inc. now owns 5,991 shares of the specialty pharmaceutical company’s stock worth $103,000 after purchasing an additional 3,921 shares during the period. Bedel Financial Consulting Inc. acquired a new stake in Valeant Pharmaceuticals in the second quarter worth $116,000. Assetmark Inc. grew its holdings in Valeant Pharmaceuticals by 409.4% in the first quarter. Assetmark Inc. now owns 11,498 shares of the specialty pharmaceutical company’s stock worth $183,000 after purchasing an additional 9,241 shares during the period. Wedbush Securities Inc. acquired a new stake in Valeant Pharmaceuticals in the second quarter worth $200,000. Finally, Meag Munich Ergo Kapitalanlagegesellschaft MBH acquired a new stake in Valeant Pharmaceuticals in the second quarter worth $236,000. Institutional investors own 46.95% of the company’s stock.

Best Financial Stocks To Own Right Now: The First of Long Island Corporation(FLIC)


Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on First of Long Island (FLIC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    First of Long Island Corp (NASDAQ:FLIC) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $21.30 and last traded at $21.60, with a volume of 237 shares. The stock had previously closed at $21.50.

Best Financial Stocks To Own Right Now: Ramco-Gershenson Properties Trust(RPT)


Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Ramco-Gershenson Properties Trust (RPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Ramco-Gershenson Properties Trust (NYSE:RPT) was upgraded by research analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research note issued on Wednesday.

  • [By Shane Hupp]

    KeyCorp set a $15.00 price target on Ramco-Gershenson Properties Trust (NYSE:RPT) in a research note published on Wednesday. The brokerage currently has a buy rating on the real estate investment trust’s stock. KeyCorp also issued estimates for Ramco-Gershenson Properties Trust’s Q3 2018 earnings at $0.32 EPS, Q4 2018 earnings at $0.32 EPS, FY2018 earnings at $1.29 EPS, Q1 2019 earnings at $0.32 EPS, Q2 2019 earnings at $0.31 EPS, Q3 2019 earnings at $0.32 EPS, Q4 2019 earnings at $0.32 EPS and FY2019 earnings at $1.27 EPS.

Best Financial Stocks To Own Right Now: Shore Bancshares Inc(SHBI)


Advisors’ Opinion:

  • [By Joseph Griffin]

    Media coverage about Shore Bancshares (NASDAQ:SHBI) has trended somewhat positive on Sunday, Accern reports. The research firm rates the sentiment of news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Shore Bancshares earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned media headlines about the bank an impact score of 47.376414932679 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Shane Hupp]

    Press coverage about Shore Bancshares (NASDAQ:SHBI) has been trending somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Shore Bancshares earned a coverage optimism score of 0.15 on Accern’s scale. Accern also assigned news headlines about the bank an impact score of 46.3784121307224 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

  • [By Joseph Griffin]

    LSV Asset Management increased its stake in Shore Bancshares Inc (NASDAQ:SHBI) by 134.4% during the 1st quarter, Holdings Channel reports. The firm owned 157,489 shares of the bank’s stock after acquiring an additional 90,289 shares during the period. LSV Asset Management’s holdings in Shore Bancshares were worth $2,970,000 as of its most recent filing with the Securities and Exchange Commission.

Best Financial Stocks To Own Right Now: Diamond Hill Investment Group Inc.(DHIL)


Advisors’ Opinion:

  • [By Logan Wallace]

    MAN Grp PLC/ADR (OTCMKTS: MNGPY) and Diamond Hill Investment Group (NASDAQ:DHIL) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends and analyst recommendations.

Best Financial Stocks To Own Right Now: eHealth Inc.(EHTH)

Advisors’ Opinion:

  • [By Joseph Griffin]

    ValuEngine lowered shares of eHealth (NASDAQ:EHTH) from a buy rating to a hold rating in a research report report published on Tuesday.

    EHTH has been the topic of several other reports. Cantor Fitzgerald boosted their price target on shares of eHealth to $22.00 and gave the stock an overweight rating in a report on Friday, May 18th. Chardan Capital initiated coverage on shares of eHealth in a report on Thursday, August 16th. They set a buy rating and a $40.00 price target on the stock. BidaskClub upgraded shares of eHealth from a buy rating to a strong-buy rating in a report on Thursday, August 16th. Finally, Zacks Investment Research cut shares of eHealth from a hold rating to a sell rating in a report on Wednesday, August 1st. Four equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of Buy and a consensus target price of $26.86.

  • [By Ethan Ryder]

    BidaskClub upgraded shares of eHealth (NASDAQ:EHTH) from a buy rating to a strong-buy rating in a research note published on Friday morning.

    A number of other research firms have also recently issued reports on EHTH. ValuEngine raised shares of eHealth from a sell rating to a hold rating in a research note on Wednesday, May 2nd. Cantor Fitzgerald lifted their price target on shares of eHealth to $22.00 and gave the company an overweight rating in a research note on Friday, May 18th. Zacks Investment Research cut shares of eHealth from a buy rating to a hold rating in a research note on Tuesday, May 15th. Finally, TheStreet raised shares of eHealth from a d rating to a c- rating in a research note on Thursday, April 26th. Three research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of Buy and an average target price of $24.00.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on eHealth (EHTH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
    Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
    DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
    eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
    Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
    SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
    Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
    Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
    Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
    ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
    Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
    Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
    Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M